SCORED Trial (Sotagliflozin) Risk Index Calculator

Clinical calculation support · Verify results before clinical use

Event-rate assumptions

Use the SCORED placebo rate or enter a different rate.

Baseline rate source
The SCORED placebo arm had 7.5 primary-endpoint events per 100 patient-years. This is an event rate, not a patient-level annual probability.
Default: 0.74 (95% CI 0.63–0.88 in the SCORED primary analysis). Change only when you have a justified alternative estimate.

About this estimate

SCORED enrolled adults with type 2 diabetes, chronic kidney disease (eGFR 25–60 mL/min/1.73 m²), and cardiovascular risk. The trial’s primary endpoint was changed during the study to the total number of cardiovascular deaths, heart-failure hospitalizations, and urgent heart-failure visits.

The reported primary-endpoint rates were 7.5 events per 100 patient-years with placebo and 5.6 with sotagliflozin; the reported HR was 0.74 (95% CI 0.63–0.88). The trial ended early because of loss of funding, with median follow-up of 16 months.

Calculation method

  • Estimated treated event rate = baseline event rate × assumed HR.
  • Event-rate difference = baseline event rate − estimated treated event rate.
  • Relative reduction implied by HR = (1 − HR) × 100%.

Important limitations

  • This is an illustrative rate projection using an aggregate trial HR, not a validated individual prediction tool.
  • The SCORED endpoint counted total events, including recurrent events. Event rates should not be relabelled as annual patient-level risks.
  • Results depend on the assumption that the chosen HR applies to the population and endpoint represented by the entered baseline rate.
  • The calculator does not account for confidence intervals, competing risks, adverse effects, contraindications, or an individual patient’s treatment eligibility.

References

Bhatt DL, Szarek M, Pitt B, et al.; SCORED Investigators.Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. N Engl J Med. 2021;384:129–139. doi:10.1056/NEJMoa2030186.Original publication (DOI) · PubMed
ClinicalTrials.gov.SCORED trial registration: NCT03315143.Trial record
Clinical disclaimer: This educational calculator summarizes aggregate trial event rates and a user-selected hazard ratio. It does not establish an individual patient’s absolute risk or treatment benefit and must not be used alone to make treatment decisions. Assess current prescribing information, contraindications, adverse effects, comorbidities, and applicable clinical guidance.